Truvestments Capital’s CareDx CDNA Stock Holding History

Truvestments Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.65K	Hold	128	–	–	﹤0.01%	947
2026 Q1	$2.22K	Hold	128	–	–	﹤0.01%	999
2025 Q4	$2.41K	Sell	128 -234	-65%	-$3.92K	﹤0.01%	876
2025 Q3	$5.26K	Hold	362	–	–	﹤0.01%	813
2025 Q2	$7.07K	Hold	362	–	–	﹤0.01%	692
2025 Q1	$6.43K	Hold	362	–	–	﹤0.01%	723
2024 Q4	$7.75K	Hold	362	–	–	﹤0.01%	644
2024 Q3	$11.3K	Buy	+362	New	+$9.01K	﹤0.01%	565
2024 Q2	–	Sell	-496	Closed	-$5.25K	–	301
2024 Q1	$5.25K	Hold	496	–	–	﹤0.01%	550
2023 Q4	$5.95K	Hold	496	–	–	﹤0.01%	576
2023 Q3	$3.47K	Hold	496	–	–	﹤0.01%	548
2023 Q2	$4.22K	Hold	496	–	–	﹤0.01%	542
2023 Q1	$4.53K	Buy	496 +242	+95%	+$3.1K	﹤0.01%	523
2022 Q4	$2.9K	Hold	254	–	–	﹤0.01%	656
2022 Q3	$4K	Hold	254	–	–	﹤0.01%	482
2022 Q2	$5K	Buy	+254	New	+$7.04K	﹤0.01%	474
2022 Q1	–	Sell	-192	Closed	-$9K	–	244
2021 Q4	$9K	Hold	192	–	–	﹤0.01%	408
2021 Q3	$12K	Hold	192	–	–	0.01%	359
2021 Q2	$18K	Hold	192	–	–	0.01%	330
2021 Q1	$13K	Hold	192	–	–	0.01%	410
2020 Q4	$13K	Buy	+192	New	+$11.1K	0.01%	400
2020 Q3	–	Sell	-454	Closed	-$16K	–	357
2020 Q2	$16K	Buy	+454	New	+$12.9K	0.02%	331
2019 Q4	–	Sell	-622	Closed	-$14K	–	220
2019 Q3	$14K	Sell	622 -28	-4%	-$775	0.01%	454
2019 Q2	$23K	Buy	650 +262	+68%	+$8.39K	0.02%	395
2019 Q1	$12K	Buy	+388	New	+$11.3K	0.01%	487
2018 Q3	$13K	Buy	+444	New	+$8.31K	0.01%	586

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truvestments Capital's CDNA Position: Q2 2026 in Review

Truvestments Capital held its CareDx (CDNA) position steady in Q2 2026 at 128 shares worth $3.65K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Truvestments Capital first reported a position in CDNA in Q3 2018 and has held it in 26 quarters since. The position peaked at $23K in Q2 2019. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Truvestments Capital held 128 shares of CareDx worth $3.65K as of Q2 2026.
Truvestments Capital left its CareDx share count unchanged in Q2 2026.
CareDx made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #947 holding.
Truvestments Capital first reported a position in CareDx in Q3 2018 and has held it in 26 quarters since.
Truvestments Capital's CareDx position peaked at $23K in Q2 2019.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.